Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ophthalmic Genet ; 39(1): 73-79, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28945494

RESUMO

PURPOSE: To investigate the clinical characteristics and genetic basis of inherited retinal degeneration (IRD) in six unrelated pedigrees from Mexico. METHODS: A complete ophthalmic evaluation including measurement of visual acuities, Goldman kinetic or Humphrey dynamic perimetry, Amsler test, fundus photography, and color vision testing was performed. Family history and blood samples were collected from available family members. DNA from members of two pedigrees was examined for known mutations using the APEX ARRP genotyping microarray and one pedigree using the APEX LCA genotyping microarray. The remaining three pedigrees were analyzed using a custom-designed targeted capture array covering the exons of 233 known retinal degeneration genes. Sequencing was performed on Illumina HiSeq. Reads were mapped against hg19, and variants were annotated using GATK and filtered by exomeSuite. Segregation and ethnicity-matched control sample analyses were performed by dideoxy sequencing. RESULTS: Six pedigrees with IRD were analyzed. Nine rare or novel, potentially pathogenic variants segregating with the phenotype were detected in IMPDH1, USH2A, RPE65, ABCA4, and FAM161A genes. Among these, six were known mutations while the remaining three changes in USH2A, RPE65, and FAM161A genes have not been previously reported to be associated with IRD. Analysis of 100 ethnicity-matched controls did not detect the presence of these three novel variants indicating, these are rare variants in the Mexican population. CONCLUSIONS: Screening patients diagnosed with IRD from Mexico identified six known mutations and three rare or novel potentially damaging variants in IMPDH1, USH2A, RPE65, ABCA4, and FAM161A genes that segregated with disease.


Assuntos
Proteínas do Olho/genética , Mutação , Degeneração Retiniana/genética , Transportadores de Cassetes de Ligação de ATP/genética , Adolescente , Adulto , Idoso , Pré-Escolar , Análise Mutacional de DNA , Proteínas da Matriz Extracelular/genética , Feminino , Determinismo Genético , Técnicas de Genotipagem , Humanos , IMP Desidrogenase/genética , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Linhagem , Fenótipo , Degeneração Retiniana/etnologia , Sequenciamento do Exoma , cis-trans-Isomerases/genética
2.
Mol Vis ; 17: 1850-61, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21850159

RESUMO

PURPOSE: Nanophthalmos is a rare genetic ocular disorder in which the eyes of affected individuals are abnormally small. Patients suffer from severe hyperopia as a result of their markedly reduced axial lengths, but otherwise are capable of seeing well unlike other more general forms of microphthalmia. To date one gene for nanophthalmos has been identified, encoding the membrane-type frizzled related protein MFRP. Identification of additional genes for nanophthalmos will improve our understanding of normal developmental regulation of eye growth. METHODS: We ascertained a cohort of families from eastern Canada and Mexico with familial nanophthalmos. We performed high density microsatellite and high density single nucleotide polymorphism (SNP) genotyping to identify potential chromosomal regions of linkage. We sequenced coding regions of genes in the linked interval by traditional PCR-based Sanger capillary electrophoresis methods. We cloned and sequenced a novel cDNA from a putative causal gene to verify gene structure. RESULTS: We identified a linked locus on chromosome 2q37 with a peak logarithm (base 10) of odds (LOD) score of 4.7. Sequencing of coding exons of all genes in the region identified multiple segregating variants in one gene, recently annotated as serine protease gene (PRSS56), coding for a predicted trypsin serine protease-like protein. One of our families was homozygous for a predicted pathogenic missense mutation, one family was compound heterozygous for two predicted pathogenic missense mutations, and one family was compound heterozygous for a predicted pathogenic missense mutation plus a frameshift leading to obligatory truncation of the predicted protein. The PRSS56 gene structure in public databases is based on a virtual transcript assembled from overlapping incomplete cDNA clones; we have now validated the structure of a full-length transcript from embryonic mouse brain RNA. CONCLUSIONS: PRSS56 is a good candidate for the causal gene for nanophthalmos in our families.


Assuntos
Olho/fisiopatologia , Hiperopia/genética , Microftalmia/genética , Serina Proteases , Animais , Sequência de Bases , Canadá , Clonagem Molecular , Estudos de Coortes , Análise Mutacional de DNA , Éxons , Olho/patologia , Ligação Genética , Genótipo , Técnicas de Genotipagem , Heterozigoto , Homozigoto , Humanos , Hiperopia/etiologia , Hiperopia/patologia , Escore Lod , Proteínas de Membrana/genética , México , Camundongos , Microftalmia/complicações , Microftalmia/patologia , Dados de Sequência Molecular , Mutação , Linhagem , Serina Proteases/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA